Clinical activity of patupilone in patients with pretreated advanced/metastatic colon cancer: results of a phase I dose escalation trial

被引:0
|
作者
B Melichar
E Casado
J Bridgewater
J Bennouna
M Campone
P Vitek
J-P Delord
J Cerman
R Salazar
J Dvorak
C Sguotti
P Urban
K Viraswami-Appanna
E Tan
J Tabernero
机构
[1] Charles University Medical School and Teaching Hospital,Department of Oncology
[2] Palackỳ University Medical School and Teaching Hospital,Medical Oncology Department
[3] Vall d’Hebron University Hospital,undefined
[4] Universitat Autònoma de Barcelona,undefined
[5] University College London Cancer Institute,undefined
[6] Centre de Recherche en Cancérologie,undefined
[7] UMR-INSERM 892,undefined
[8] Institut de Cancérologie de l’Ouest/René Gauducheau,undefined
[9] Bd. Jacques Monod,undefined
[10] Institute of Radiation Oncology,undefined
[11] Charles University First Medical School,undefined
[12] Institut Claudius Regaud,undefined
[13] 20-24 rue de Pont Saint Pierre,undefined
[14] Novartis Pharma AG,undefined
[15] Oncology Clinical Development,undefined
[16] Novartis Pharmaceuticals Corporation,undefined
[17] One Health Plaza,undefined
来源
British Journal of Cancer | 2011年 / 105卷
关键词
dose escalation; epothilone B; metastatic colon cancer; microtubule stabiliser; patupilone;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1646 / 1653
页数:7
相关论文
共 50 条
  • [21] A phase I trial of gemcitabine in combination with patupilone in patients with advanced solid tumors
    Schelman, William
    Morgan-Meadows, Sherry
    Bailey, Howard
    Holen, Kyle
    Thomas, James P.
    Eickhoff, Jens
    Brandon, Heidi
    Oliver, Kate
    Alberti, Dona
    Wilding, George
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (04) : 727 - 733
  • [22] Patupilone in chemotherapy-pretreated patients with advanced colorectal cancer (CRC) receiving nutritional support and intensive diarrea management: A phase I multicenter trial
    Melichar, Bohuslav
    Casado, Esther
    Tabernero, Josep
    Bridgewater, John
    Bennouna, Jaafar
    Delord, Jean-Pierre
    Sanna, Lilian
    Sklenar, Ivo
    Cheung, Wing
    Johri, Anandhi
    [J]. ANNALS OF ONCOLOGY, 2006, 17
  • [23] A phase lb and pharmacokinetic trial of patupilone combined with carboplatin in patients with advanced cancer
    Forster, Martin
    Kaye, Stan
    Oza, Amit
    Sklenar, Ivo
    Johri, Anandhi
    Cheung, Wing
    Zaknoen, Sara
    Gore, Martin
    [J]. CLINICAL CANCER RESEARCH, 2007, 13 (14) : 4178 - 4184
  • [24] Phase I trial of radiation dose escalation with concurrent weekly full-dose gemcitabine in patients with advanced pancreatic cancer
    McGinn, CJ
    Zalupski, MM
    Shureiqi, I
    Robertson, JM
    Eckhauser, FE
    Smith, DC
    Brown, D
    Hejna, G
    Strawderman, M
    Normolle, D
    Lawrence, TS
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (22) : 4202 - 4208
  • [25] A phase I trial of gemcitabine in combination with patupilone in patients with advanced solid tumors
    William Schelman
    Sherry Morgan-Meadows
    Howard Bailey
    Kyle Holen
    James P. Thomas
    Jens Eickhoff
    Heidi Brandon
    Kate Oliver
    Dona Alberti
    George Wilding
    [J]. Cancer Chemotherapy and Pharmacology, 2008, 62 : 727 - 733
  • [26] A phase I dose escalation trial of BCD-145 in patients with unresectable or metastatic melanoma
    Kryukov, Fedor
    Semiglazova, Tatiana
    Moiseenko, Vladimir
    Odintsova, Svetlana
    Sorokina, Irina
    Menshchikova, Ekaterina
    Zinkina-Orikhan, Arina
    Kushakova, Anna
    Fogt, Sergey
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [27] Phase I dose escalation clinical trial of phenylbutyrate sodium administered twice daily to patients with advanced solid tumors
    Camacho, Luis H.
    Olson, Jon
    Tong, William P.
    Young, Charles W.
    Spriggs, David R.
    Malkin, Mark G.
    [J]. INVESTIGATIONAL NEW DRUGS, 2007, 25 (02) : 131 - 138
  • [28] Phase I dose escalation clinical trial of phenylbutyrate sodium administered twice daily to patients with advanced solid tumors
    Luis H. Camacho
    Jon Olson
    William P. Tong
    Charles W. Young
    David R. Spriggs
    Mark G. Malkin
    [J]. Investigational New Drugs, 2007, 25 : 131 - 138
  • [29] Phase I Dose-escalation Clinical Trial of HF10 Oncolytic Herpes Virus in 17 Japanese Patients with Advanced Cancer
    Kasuya, Hideki
    Kodera, Yasuhiro
    Nakao, Akimasa
    Yamamura, Kazuo
    Tan Gewen
    Wu Zhiwen
    Hotta, Yoshihiro
    Yamada, Suguru
    Fujii, Tsutomu
    Fukuda, Saori
    Tsurumaru, Naoko
    Kuwahara, Toshie
    Kikumori, Toyone
    Koide, Yusuke
    Fujimoto, Yasushi
    Nakashima, Tsutomu
    Hirooka, Yoshiki
    Shiku, Hiroshi
    Tanaka, Maki
    Takesako, Kazuto
    Kondo, Touru
    Aleksic, Branko
    Kawashima, Hiroki
    Goto, Hidemi
    Nishiyama, Yukihiro
    [J]. HEPATO-GASTROENTEROLOGY, 2014, 61 (131) : 599 - 605
  • [30] Safety and Efficacy of Patupilone in Patients With Advanced Ovarian, Primary Fallopian, or Primary Peritoneal Cancer: A Phase I, Open-Label, Dose-Escalation Study
    Huinink, Wim W. ten Bokkel
    Sufliarsky, Jozef
    Smit, Willem M.
    Spanik, Stanislav
    Wagnerova, Maria
    Hirte, Hal W.
    Kaye, Stan
    Johri, Anandhi R.
    Oza, Amit M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (19) : 3097 - 3103